Massive pharma company exec: We want to ‘love the Communist party’

Daily Caller News Foundation

Pharmaceutical giant AstraZeneca’s China president and global executive vice president pledged that the company would be patriotic in China and “love” the country’s ruling communist party, according to Reuters.

“Build a local, transnational company that loves the Communist Party and loves the country,” Wang said, according to Reuters.

Weng Lei made the comments at a Friday presentation to a crowd of several hundred during an event marking AstraZeneca’s 30 years of business in China, according to Reuters. AstraZeneca, the largest drug producer in China, made 13% of its sales there in 2022 and recently spent $450 million on a China-based inhaler factory.

AstraZeneca declined to clarify whether senior management had approved the quotes from Lei and wouldn’t say what his comments meant for the company’s plans in the country, according to Reuters. The company received $1.2 billion in American taxpayer money in 2020 to develop its COVID-19 vaccine, which brought in $4 billion in sales in 2021.

AstraZeneca did not respond to the Daily Caller News Foundation’s request for comment.

All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.

Comment

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. Thank you for partnering with us to maintain fruitful conversation.

BPR INSIDER COMMENTS

Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!

Latest Articles